The Biomarkers Consortium project concepts for new research projects should:

  • Address a significant unmet scientific need
  • Focus on translational biomarkers research
  • Address critical gaps in a major therapeutic area
  • Leverage pre-existing resources wherever possible
  • Generate multi-stakeholder scientific interest and funding support

Project Concept Submission Process: Researchers interested in submitting a Project Concept to The Biomarkers Consortium should

  1. Contact the Scientific Program Manager for the appropriate therapeutic area Steering Committee

    CANCER STEERING COMMITTEE
    Stacey Adam, Ph.D.
    301-435-8364, sadam@fnih.org

    INFLAMMATION and IMMUNITY STEERING COMMITTEE
    Areas of interest include chronic inflammatory and autoimmune diseases and disorders often resulting from dysregulation of the immune system (e.g., arthritis, lupus, COPD, IBD).
    Steve Hoffmann, M.S.
    301-443-2102, shoffmann@fnih.org

    METABOLIC DISORDERS STEERING COMMITTEE
    Areas of interest include metabolic disorders (e.g., diabetes, obesity), aging (e.g., muscle weakness, bone quality), and cardiovascular disease (e.g., atherosclerosis).
    Joseph P. Menetski, Ph.D.
    301-594-6596 jmenetski@fnih.org

    NEUROSCIENCE STEERING COMMITTEE
    Areas of interest include a broad range of neuroscience projects
    Rosa Canet-Aviles, Ph.D.
    301-402-5346, rcanet-aviles@fnih.org

    OTHER THERAPEUTIC AREAS, OR OTHER QUESTIONS – Researchers with project concepts outside of the above Steering Committees please contact:
    Cheryl Melencio
    301-402-4970, cmelencio@fnih.org

  2. Review The Consortium policies and procedures relating to intellectual property, data sharing, antitrust, selection and award of grants/contracts, confidentiality, conflict of interest

     

  3. Complete the Project Concept Form and submit to the appropriate Scientific Program Manager.

Project Concept Review and Approval Process: Submissions are reviewed on a rolling basis by the Steering Committees, each of which is composed of representatives from the academic, government, industry, and not-for-profit sectors. For committee membership, click here.

Approval of Project Concepts is based on:

  • Suitability to the goals of The Biomarkers Consortium
  • Scientific importance
  • Clinical relevance
  • Regulatory impact
  • Feasibility and the potential to generate multi-stakeholder funding support

If a project idea is approved for further development and implementation, the Foundation for the National Institutes of Health will seek funding to support the resulting project and manage its execution.

Front Page: